Fighting PKD Together

Since 1982, passionate patients have inspired and supported the PKD Foundation’s efforts to fight PKD. Together, we’ve advanced basic PKD research into PKD drug development. Treatments for PKD are finally within reach! Now, more than ever, we need to unite as a community - join us in this unfinished fight.

 

 
 
  • Possible new therapy has been identified
    September 23, 2010 |  Research & Medicine

    Researchers at pharmaceutical company Genzyme and the University of Michigan have identified a possible new therapy. Compound Genz-123346, a specific inhibitor of the synthesis of GlyCer was tested in three cystic mouse models and showed a dose-dependent improvement in symptoms.

[1]  2  3  


More News

 

 

Fri, 10 Feb 2012 07:17:47 -0500

Here we demonstrate restoration of a genomic mutation heterozygous for Pkd1 (polycystic kidney disease 1) deletion (Pkd1(+/-) to Pkd1(+/R+)) by spontaneous mitotic recombination. Notably, recombination between homologous chromosomes occurred at ...

Donate New Year

 

 

Loading

PKD Foundation on Twitter

 
©2010, PKD Foundation  · The PKD Foundation is a 501 (c)(3), 509 (a)(1) public charity.